People and Business News – 7/23
The latest people and business news from the past month, all in one place.
People News
Suvoda has tapped Irena Lerentracht Webster to join its board of directors. With over 20 years of experience at a drug development leader at the sponsor, CRO, and site levels, Webster currently serves as VP head of program strategy & development operations for Arkuda Therapeutics.
Parexel announced the appointment of Anne G. Kasmar, MD, MSc, as SVP, Global Therapeutic Area Head — Infectious Disease and Vaccines. Previously, Kasmar was a lead medical director at Genentech, South San Francisco, California, where she oversaw cross-functional teams researching new therapies for graft-versus-host disease as well as novel antibiotics.
ArisGlobal revealed the hiring of expansion of its executive team. Ann-Marie Orange joins as chief technology officer, after previously serving as CIO for TransUnion. Glenn Renzulli has been recruited as the new chief financial officer. Prior to joining ArisGlobal, Renzulli worked as chief financial officer of Paya.
Business News
Dr. Vince Clinical Research announced the receipt of a Two Green Globes certification to its clinical pharmacology unit
M3 Wake Research is expanding operations into Charleston, SC with the opening of a clinical research practice.
Phastar has been certified as a Certified B Corporation®, coming after a 12-month review to ensure protocols and procedures reflect the company’s commitment to high environment, social, and governance (EGS) standards.
OneStudyTeam announced that StudyTeam is now being used by more than 4,000 clinical research sites outside the United States, bringing the total to 7,000 in more than 100 countries.
Almac Group opened a a new custom-built GMP warehouse and dispatch hub at its Global Headquarters in Craigavon, UK.
AARDEX Group announced its place as a founding member of the CancerX initiative, aiming to drive innovation and improve follow up for cancer patients.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
